152 related articles for article (PubMed ID: 23188538)
21. LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.
Yang H; Xiong FX; Lin M; Yang Y; Nie X; Zhou RL
J Cancer Res Clin Oncol; 2010 Feb; 136(2):275-81. PubMed ID: 19690886
[TBL] [Abstract][Full Text] [Related]
22. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis.
Ohkubo T; Yamamoto J; Sugawara Y; Shimada K; Yamasaki S; Makuuchi M; Kosuge T
J Am Coll Surg; 2000 Dec; 191(6):657-60. PubMed ID: 11129815
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
Zhou LX; Yan LN
Ai Zheng; 2006 Jun; 25(6):736-9. PubMed ID: 16764771
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
26. Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection: a matched study.
Wang DD; Wu LQ; Wang ZS
Hepatobiliary Pancreat Dis Int; 2016 Dec; 15(6):626-632. PubMed ID: 27919852
[TBL] [Abstract][Full Text] [Related]
27. Effects of location and extension of portal vein tumor thrombus on long-term outcomes of surgical treatment for hepatocellular carcinoma.
Chen XP; Qiu FZ; Wu ZD; Zhang ZW; Huang ZY; Chen YF; Zhang BX; He SQ; Zhang WG
Ann Surg Oncol; 2006 Jul; 13(7):940-6. PubMed ID: 16788755
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
[TBL] [Abstract][Full Text] [Related]
29. Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumor thrombus：a multicenter study.
Xiang X; Lau WY; Wu ZY; Zhao C; Ma YL; Xiang BD; Zhu JY; Zhong JH; Li LQ
Eur J Surg Oncol; 2019 Aug; 45(8):1460-1467. PubMed ID: 31005471
[TBL] [Abstract][Full Text] [Related]
30. Actual long-term survival in HCC patients with portal vein tumor thrombus after liver resection: a nationwide study.
Chen ZH; Zhang XP; Lu YG; Li LQ; Chen MS; Wen TF; Jia WD; Zhou D; Li J; Yang DH; Zhen ZJ; Xia YJ; Fan RF; Huang YQ; Zhang Y; Wu XJ; Hu YR; Tang YF; Lin JH; Zhang F; Zhong CQ; Guo WX; Shi J; Lau J; Cheng SQ
Hepatol Int; 2020 Sep; 14(5):754-764. PubMed ID: 32253678
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
32. Characterization of somatostatin receptor 2 and 5 expression in operable hepatocellular carcinomas.
Li S; Liu Y; Shen Z
Hepatogastroenterology; 2012 Oct; 59(119):2054-8. PubMed ID: 22640914
[TBL] [Abstract][Full Text] [Related]
33. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus.
Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ
World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for hepatocellular carcinoma presenting with macroscopic portal vein tumor thrombus.
Sakata H; Konishi M; Ryu M; Kinoshita T; Satake M; Moriyama N; Ochiai T
Hepatogastroenterology; 2004; 51(60):1575-80. PubMed ID: 15532781
[TBL] [Abstract][Full Text] [Related]
35. AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.
Yaprak O; Akyildiz M; Dayangac M; Demirbas BT; Guler N; Dogusoy GB; Yuzer Y; Tokat Y
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):256-61. PubMed ID: 22672818
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
37. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
38. Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance.
Lin SB; Zhou L; Liang ZY; Zhou WX; Jin Y
J Clin Pathol; 2017 Sep; 70(9):754-759. PubMed ID: 28202495
[TBL] [Abstract][Full Text] [Related]
39. Extent of portal vein tumour thrombosis in patients with hepatocellular carcinoma: The more, the worse?
Mähringer-Kunz A; Steinle V; Düber C; Weinmann A; Koch S; Schmidtmann I; Schotten S; Hinrichs JB; Graafen D; Pinto Dos Santos D; Galle PR; Kloeckner R
Liver Int; 2019 Feb; 39(2):324-331. PubMed ID: 30318826
[TBL] [Abstract][Full Text] [Related]
40. Loss of SFRP1 Expression Is Associated with Poor Prognosis in Hepatocellular Carcinoma.
Davaadorj M; Imura S; Saito YU; Morine Y; Ikemoto T; Yamada S; Takasu C; Hiroki T; Yoshikawa M; Shimada M
Anticancer Res; 2016 Feb; 36(2):659-64. PubMed ID: 26851021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
